- Home
- IVA vs ASA Comparison
IVA vs ASA Comparison
Compare IVA & ASA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVA
- ASA
- Stock Information
- Founded
- IVA 2011
- ASA 1958
- Country
- IVA France
- ASA United States
- Employees
- IVA N/A
- ASA N/A
- Industry
- IVA Biotechnology: Pharmaceutical Preparations
- ASA Precious Metals
- Sector
- IVA Health Care
- ASA Industrials
- Exchange
- IVA Nasdaq
- ASA Nasdaq
- Market Cap
- IVA 769.0M
- ASA 697.1M
- IPO Year
- IVA 2020
- ASA N/A
- Fundamental
- Price
- IVA $6.24
- ASA $46.95
- Analyst Decision
- IVA Strong Buy
- ASA
- Analyst Count
- IVA 7
- ASA 0
- Target Price
- IVA $16.00
- ASA N/A
- AVG Volume (30 Days)
- IVA 61.2K
- ASA 156.1K
- Earning Date
- IVA 09-29-2025
- ASA 10-17-2025
- Dividend Yield
- IVA N/A
- ASA 0.13%
- EPS Growth
- IVA N/A
- ASA 335.96
- EPS
- IVA N/A
- ASA 19.90
- Revenue
- IVA $19,929,536.00
- ASA $3,982,215.00
- Revenue This Year
- IVA N/A
- ASA N/A
- Revenue Next Year
- IVA N/A
- ASA N/A
- P/E Ratio
- IVA N/A
- ASA $2.29
- Revenue Growth
- IVA N/A
- ASA 99.75
- 52 Week Low
- IVA $1.60
- ASA $19.37
- 52 Week High
- IVA $6.55
- ASA $47.75
- Technical
- Relative Strength Index (RSI)
- IVA 60.61
- ASA 78.32
- Support Level
- IVA $5.59
- ASA $44.00
- Resistance Level
- IVA $6.55
- ASA $46.79
- Average True Range (ATR)
- IVA 0.33
- ASA 1.40
- MACD
- IVA 0.01
- ASA 0.12
- Stochastic Oscillator
- IVA 78.02
- ASA 89.27
About IVA Inventiva S.A. American Depository Shares
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.
About ASA ASA Gold and Precious Metals Limited
ASA Gold And Precious Metals Ltd is a closed-end, non-diversified investment company. Its objective is to provide long-term capital appreciation through investing in companies engaged in the exploration for, development of projects, or mining of precious metals and minerals.